Modern nonhormonal possibilities of treatment of polycystic ovary syndrome in obese women

Т. Ф Татарчук, І. Ю. Ганжий, Н. Ю. Педаченко, І. М. Капшук

Abstract


The aim of the study was to explore the use of multicomponent herbal preparation in treatment of polycystic ovary syndrome (PCOS) in women with obesity and normal levels of ovarian androgens.

We examined 120 patients with PCOS and 30 healthy women. All subjects were divided into subgroups according to the use of a component of a treatment complex. The authors found that the use of the developed approach with the inclusion in the scheme of treatment multicomponent herbal preparation gives possible normalize the function of adipose tissue and improve its relationship with the pituitary-adrenal and pituitar-ovarian systems, normalize the menstrual cycle. COC use in patients with obesity and normal androgen level leads only to some cosmetic effect and the regulation of the cycle for the period of treatment, without affecting or impairing the other types of metabolism, leading to destabilization, deepening of existing violations and the transition from functional into organic changes.


Keywords


polycystic ovary syndrome; obesity; adipocytokines

References


Mukherjee S Polycystic ovary syndrome. Review/ Mukherjee S, Maitra A// Indian J Med Res. – 2010. – Vol.131. – P. 743–760.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)// Hum Reprod. – 2004. – Vol.19. – P.41-47.

Lindsay RS Adiponectin and development of type 2 diabetes in the Pima Indian population / Lindsay RS, Funahashi T, Hanson RL [et al.] // Lancet. –2002. – Vol. 360. – P.57–58.

Iniguez G Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity / Iniguez G, Soto N, Avila A [et al.] // J. Clin. Endocrinol. Metab. – 2004. – Vol. 89. – P. 5500–5503.

Ducluzeau PH Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome / Ducluzeau PH, Cousin P, Malvoisin E [et al.] // Ibid. – 2003. – Vol. 88. – P. 3626–3631.

Yilmaz M Serum resistin and adiponectin levels in women with polycystic ovary syndrome / Yilmaz M, Bukan N, Dtvirci H [et al.] // International Society of Gynecological Endocrinology. – 2009. – №. 32/4. – P. 68–74.

Gevorgyan MAClinic, diagnosis and treatment of polycystic ovary syndrome / MA Gevorgyan, IB Manukhin, LB Studenaya [etc.] // ZHROAG. – 2008, № 4. – P. 3–20.

Gluhov NV Diseases associated with polycystic ovary syndrome and metabolic syndrome / NV Gluhov, SJ Chubrieva, NA Belyakov // Efferent Therapy. – 2007. – Vol.13. – № 1. – P. 17–19.

Grishchenko VI Polycystic ovary syndrome as a cause of endocrine infertility / Grishchenko VI, Grishchenko NG, Zagrebelnaya IV [etc.] // Medical Aspects of Women’s Health. – 2010. – № 1 (28.) – P. 5–12.

Gopchuk EN Optimizing the diagnosis of polycystic ovary syndrome / E. Gopchuk // Proceedings of the Association of Obstetricians of Ukraine. – K.: Іntermed, 2011. – P. 189–194.

Dedov II Endocrinology / Dedov II, GA Melnichenko. – Moscow: Triada-X, 2008. – 289 p.

Naumenko VG Hyperandrogenism status / VG Naumenko // Medical Aspects of Women’s Health. – 2011. – № 1 (40). – P. 5–102.

Zykova TD Metabolic features of polycystic ovary syndrome in women with normal and overweight / TD Zykova, AV Strelkova, BA Savenko, GA Melnichenko // Diabetes. – 2003. – № 1 (18). – P. 16–21.

Tatarchuk TF Adipose tissue and the reproductive system of women / Tatarchuk TF, Cossey NV, Ganji IY // Health Protection of Ukraine. – 2008. – № 24/1. – P. 14–16.

Shilin DE Polycystic Ovary Syndrome Diagnostic International Consensus (2003) and the modern ideology therapy / DE Shilin // Consilium Medicum. – 2004. – T. 06, № 9. – P. 27–31.

Svetlakov AV Leptin and blood lipid profile in women with different types of obesity / Svetlakov AV, Yamanova MV, Filippov OS, Mahalova NA // Problems of Reproduction. – 2001. – № 6. – P. 29–32.

Koval SN Adipose tissue adiponectin hormone and its role in the pathogenesis of the metabolic syndrome and cardiovascular diseases. Hypoadiponectinemia as a therapeutic target (review) / Koval SN, Snegursky IA // Journal of NAMS of Ukraine. – 2011. – V. 17, № 2. – P. 174–185.

Dedov II Polycystic ovary syndrome and metabolic syndrome / Dedov II, Butrova SA // Obesity and Metabolism. – 2006. – № 1. – P. 30–40.


GOST Style Citations


Геворкян М.А. Клиника, диагностика и лечение синдрома поликистозных яичников / М.А. Геворкян, И.Б. Манухин, Л.Б. Студеная [и др.] // ЖРОАГ. – 2008, № 4.– С. 3–20.

Глухов Н.В. Заболевания, ассоциированные с синдромом поликистозных яичников и метаболическим синдромом / Н.В. Глухов, С.Ю. Чубриева, Н.А. Беляков // Эфферентная терапия. – 2007. – ТОМ 13. – № 1. – С.17–19.

Mukherjee S Polycystic ovary syndrome. Review/ Mukherjee S, Maitra A// Indian J Med Res. – 2010. – Vol.131. – P. 743–760.

Грищенко В.И. Синдром поликистозных яичников как причина эндокринного бесплодия/ В.И. Грищенко, Н.Г. Грищенко, И.В. Загребельная [и др.] // Медицинские аспекты здоровья женщины. – 2010. – № 1 (28). – С. 5–12.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)// Hum Reprod. – 2004. – Vol.19. – P.41-47.

Гопчук Е.Н. Оптимизация диагностики синдрома поликистозных яичников / Е.Н. Гопчук // Збірник наукових праць Асоціації акушерів-гінекологів України. – К.: Інтермед, 2011. – С. 189-194.

Дедов И.И. Эндокринология / Дедов И.И., Мельниченко Г.А. – М.: Триада-Х, 2008. – 289 с.

Науменко В.Г. Гиперандрогенные состояния / Науменко В.Г. // Медицинские аспекты здоровья женщины. – 2011. – № 1 (40). – С. 5–102.

Зыкова Т.Д. Метаболические особенности синдрома поликистозных яичников у женщин с нормальной и избыточной массой тела / Зыкова Т.Д., Стрелкова А.В., Савенко Б.А., Мельниченко Г.А. // Сахарный диабет. – 2003. – № 1(18). – С.16-21.

Татарчук Т.Ф. Жировая ткань и репродуктивная система женщины / Татарчук Т.Ф., Косей Н.В., Ганжий И.Ю. // Здоров’я України. – 2008. – № 24/1. – С. 14–16.

Шилин Д.Е. Синдром поликистозных яичников. Международный диагностический консенсус (2003 г.) и современная идеология терапии / Шилин Д.Е.// Consilium Medicum. – 2004. – Т. 06, № 9. – С. 27–31.

Светлаков А.В. Лептин и липидный спектр крови у женщин с разными типами ожирения / Светлаков А.В., Яманова М.В., Филиппов О.С., Махалова Н.А. // Проблемы репродукции. – 2001. – № 6. – С. 29–32.

Коваль С.Н. Гормон жировой ткани адипонектин и его роль в патогенезе метаболического синдрома и сердечно-сосудистых. Гипоадипонектинемия как терапевтическая мишень (обзор литературы) / Коваль С.Н., Снегурская И.А. // Журнал НАМН України. – 2011. – Т. 17, № 2. – С. 174–185.

Lindsay RS Adiponectin and development of type 2 diabetes in the Pima Indian population / Lindsay RS, Funahashi T, Hanson RL [et al.] // Lancet. –2002. – Vol. 360. – P.57–58.

Iniguez G Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity / Iniguez G, Soto N, Avila A [et al.] // J. Clin. Endocrinol. Metab. – 2004. – Vol. 89. – P. 5500–5503.

Ducluzeau PH Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome / Ducluzeau PH, Cousin P, Malvoisin E [et al.] // Ibid. – 2003. – Vol. 88. – P. 3626–3631.

Yilmaz M Serum resistin and adiponectin levels in women with polycystic ovary syndrome / Yilmaz M, Bukan N, Dtvirci H [et al.] // International Society of Gynecological Endocrinology. – 2009. – №. 32/4. – P. 68–74.

Дедов И.И. Синдром поликистозных яичников и метаболический синдром / И.И. Дедов, С.А. Бутрова // Ожирение и метаболизм. – 2006. – № 1. – С. 30–40.





DOI: http://dx.doi.org/10.18370/2309-4117.2013.13.14-21

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)